Dupuytren's Contracture, Diabetes and Weight: What the Evidence Shows

Dupuytren's contracture is a slow thickening and scarring of the tissue under the skin of the palm, which forms lumps and cords and can gradually pull one or more fingers into a bent position that will not straighten ^[1]. Diabetes is one of its clearest risk factors: across 32 studies, people with diabetes had about three times the odds of the condition ^[4]. Body weight runs the other way. In several large studies, and in genetic analyses, a higher BMI was linked to a lower chance of Dupuytren disease ^[3][7][8]. This review explains what that means, what blood sugar has to do with it, how the treatments compare, and what is not yet known about GLP-1 drugs.

The honest summary

• It is common and mostly inherited. Pooled studies put worldwide prevalence at about 8%, and genetic factors are thought to account for most of the risk ^[1][2].
• Diabetes is a consistent risk factor. The odds were about 3 times higher with diabetes in a meta-analysis ^[4], and genetic analysis points to long-term high blood sugar as a cause ^[5].
• Higher body weight is linked to less Dupuytren disease, not more. Each step up in obesity class carried about 23% lower odds in UK Biobank ^[3], and two genetic studies agree ^[5][8], though a third found no clear effect ^[9].
• That is not a reason to gain weight. The effect is modest, and the same genetic data show high blood sugar raising risk ^[5].
• Treatment releases the finger but does not cure the disease. Recurrence is common after every option, and surgery held up best at two years in a randomized trial ^[1][11].
• There are no GLP-1 data. No study has looked at GLP-1 drugs and Dupuytren disease.

What Dupuytren's contracture is

The condition is a progressive scarring (fibrosis) of the palmar fascia, the sheet of tough tissue that lies just under the skin of the palm. It first shows up as firm nodules, then as cords that can shorten and stop the fingers from straightening fully ^[1]. How fast it moves varies greatly from one person to the next, and some people never develop a contracture at all. It is not the same as trigger finger, where a finger catches or locks as the tendon slides, although the two often occur together and share risk factors.

A worldwide meta-analysis of 85 studies estimated a prevalence of 8.2%, with the highest rate in the type 1 diabetes subgroup (34.1%) ^[2]. In UK Biobank, being male tripled the odds (OR 3.23) and the odds rose with every year of age ^[3]. A German review estimated that genetic factors account for about 80% of the factors involved, and listed diabetes, liver disease, epilepsy and long-term use of vibrating tools as associated conditions ^[1].

Diabetes and blood sugar

A 2018 meta-analysis of 32 studies found that people with diabetes had about three times the odds of Dupuytren disease (OR 3.06, adjusted for age) ^[4]. The link looked somewhat stronger for type 1 than for type 2 diabetes, but that difference was not statistically significant. Liver disease (OR 2.92) and epilepsy (OR 2.80) carried similar associations.

Blood sugar control seems to matter, not only the diagnosis. In UK Biobank, diabetes with complications was linked to 2.59 times the odds, and within that group each 10 mmol/mol rise in HbA1c (about 0.9 percentage points on the scale US labs use) added 31% to the odds ^[3]. A genetic study in 379,708 people used inherited gene variants as a natural experiment, a method called Mendelian randomization. Genetically higher HbA1c raised the odds of Dupuytren disease (OR 1.17 per 10 mmol/mol), alongside frozen shoulder, carpal tunnel syndrome and trigger finger, and the authors concluded these hand and arm conditions should be considered complications of diabetes ^[5].

How long someone has had diabetes may matter as much as the HbA1c number. In a Swedish register study of 96,039 adults with diabetes, longer diabetes duration consistently raised the risk, while higher HbA1c showed only a trend in type 1 diabetes that did not reach statistical significance ^[6]. A 2025 review in Diabetes Care describes Dupuytren disease, trigger finger, frozen shoulder and carpal tunnel syndrome as occurring two to three times more often in diabetes, more so after age 50 and with longer diabetes duration, with glycation of collagen and low-grade inflammation as suspected causes ^[13].

Body weight: the inverse link

For most conditions on this site, more weight means more risk. Dupuytren disease is an exception, and several independent lines of evidence point the same way.

• A large US health-system study. Among more than 2 million adult members of Kaiser Permanente Southern California, 14,844 were diagnosed with Dupuytren disease, and after accounting for age, race and sex, the risk fell as BMI rose ^[7].
• UK Biobank. In 4,148 cases and 397,425 controls, each higher obesity class carried about 23% lower odds (OR 0.774) ^[3].
• People with type 2 diabetes. In the Swedish register, higher BMI was linked to lower risk in both men and women with type 2 diabetes ^[6].
• Genetic studies. One Mendelian randomization study estimated 28% lower odds for each 4.8-point rise in genetically predicted BMI ^[8]; the larger 2024 analysis found a smaller effect, about 6% lower odds per 5 points ^[5].

Not every analysis agrees. A 2026 Mendelian randomization study that combined UK Biobank with the Finnish FinnGen cohort found no convincing causal effect of obesity traits on Dupuytren disease, while confirming diabetes and alcohol intake as likely causes ^[9]. The fair reading is that higher BMI is reliably associated with less Dupuytren disease, and may be mildly protective, but the size of any causal effect is uncertain. Nobody knows why; the researchers who first reported the link said further work is needed to find the cause ^[7].

What about weight loss?

Only one study speaks to it directly, and it points the uncomfortable way. A Swedish nationwide cohort compared 34,959 people who had bariatric surgery with 54,769 matched people with obesity who did not ^[10]. The surgery group had a 30% higher risk of a new Dupuytren diagnosis (HR 1.30), rising to 63% higher after more than five years of follow-up, and the authors concluded that substantial weight loss is associated with an increased risk. It is a single observational study that cannot prove cause, and it says nothing about the other health effects of bariatric surgery. It does mean that nobody should expect weight loss to protect against Dupuytren disease.

Alcohol, smoking and cholesterol

In UK Biobank, smoking, alcohol intake and higher HDL cholesterol were each associated with higher odds of Dupuytren disease ^[3]. The genetic study supported alcohol as a likely cause, but not smoking intensity ^[9]. Cutting back on alcohol is reasonable for many reasons; GLP-1 drugs are being studied for alcohol use, as covered in GLP-1 drugs and alcohol use disorder, but no study has linked that to Dupuytren disease.

Treatment: what the trials show

There is no cure. Treatment releases the bent finger, and the disease can come back. A German review put the five-year recurrence rate after limited fasciectomy (surgical removal of the diseased tissue) at 12% to 73% depending on the study, and reported recurrence in 85% of people after needle fasciotomy (cutting the cord with a needle through the skin) after an average of 2.3 years; needle treatment can be repeated and recovers faster ^[1]. For lumps in the palm without a bent finger, the review lists only conservative measures such as padded gloves ^[1].

Two randomized trials compared the main options directly.

• Finland, 302 people. Surgery, needle fasciotomy and collagenase injection (an enzyme that softens the cord so it can be snapped) had similar success at three months, 71% to 73%. At two years, success held at 78% after surgery but was lower after needle fasciotomy (50%) and collagenase (65%), even with retreatments ^[11].
• United Kingdom, 672 people. Collagenase was not as good as limited fasciectomy on a patient-rated hand score at one year (17.8 versus 11.9 points, where lower is better). It had fewer moderate or severe complications (1.8% versus 5.1%) but more repeat treatment for recurrence (14.6% versus 3.4%) ^[12].

The choice is a trade-off between a quicker, less invasive procedure now and a more durable result. Having diabetes was linked to slower symptom resolution and higher recurrence across these hand conditions in the Diabetes Care review ^[13], which is worth raising with a hand surgeon.

What is known about GLP-1 drugs

Nothing direct. We found no published study of GLP-1 drugs such as semaglutide or tirzepatide and Dupuytren disease. Two parts of the evidence above pull in opposite directions. The genetic data suggest that long-term high blood sugar causes some Dupuytren disease ^[5], and these drugs are approved to lower blood sugar in type 2 diabetes. But higher BMI is linked to lower risk ^[3], and the one study of large weight loss linked it to more Dupuytren disease ^[10]. Which effect would win in a person taking a GLP-1 drug, if either matters at all, is unknown.

The related hand and shoulder conditions have early database studies. For trigger finger they conflict, as covered in trigger finger, diabetes and GLP-1 drugs, and for frozen shoulder they point toward more cases, not fewer, as covered in frozen shoulder and diabetes. Those findings cannot be carried over to Dupuytren disease. If you are planning a procedure while on a GLP-1, ask about the anesthesia guidance in GLP-1 drugs before surgery.

Practical guidance

• Lumps in the palm without a bent finger are managed conservatively. The course varies widely between people ^[1].
• See a hand specialist if a finger will not straighten or the contracture is getting in the way of daily life; the trade-offs between procedures are real ^[11][12].
• If you have diabetes, bring it up. Diabetes is linked to more Dupuytren disease and other hand problems, and long-term high blood sugar appears to be a cause ^[5][13].
• Do not expect weight loss to help this condition, and do not avoid weight loss because of it. The weight link is modest and its cause is unclear ^[9].
• Hand numbness is a separate problem that needs its own assessment. A common cause is carpal tunnel syndrome, which, unlike Dupuytren disease, is more common with higher weight ^[5].